I'm LongbridgeAI, I can summarize articles.Viatris reported strong Q2 results, with Non-GAAP EPS of $0.69 beating estimates by $0.09 and revenue reaching $3.75B, surpassing forecasts by $80M. The company maintained double-digit growth in Greater China. However, analysts note potential profit softening due to pressure on generics business and suggest caution following a 54% stock surge over 16 months, with some rating downgrades issued.
More on Viatris Viatris: A Reasonable Valuation Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run Viatris Soared 54%: Time To Be More Careful (Rating Downgrade) Viatris Non-GAAP EPS of $0.69 beats by $0.09, revenue of $3.75B beats by $80M Viatris Q2 preview: Analysts see profits softening amid pressure on generics bu...